Future Tense

How to Understand Your Risk of COVID Right Now

The very small figure of a tightrope walker is seen against a blue sky.
Getty Images Plus

A version of this article first appeared in Katelyn Jetelina’s newsletter, Your Local Epidemiologist.

We’re coming to the end of a wave. The CDC is changing guidance. Schools are removing mask mandates. More than 253 million people have at least one dose of the vaccine. A lot is changing, and today looks very different from March 2020. Together, many of us are reflecting on our own risk tolerance and possibly recalibrating.

Throughout the pandemic, public health practitioners (including me) have been doing a terrible job of accurately communicating risk. Last week a New York Magazine article even said: “There isn’t one voice in public health that Americans can turn to and think, ‘This person is going to help me think about risk’ … this kind of bureaucratic timidity and caution … has been quite damaging.”

Advertisement
Advertisement
Advertisement
Advertisement

Contextualizing really small numbers and really large numbers is close to impossible for human brains, so communicating risk accurately and without bias is crucial. But lack of risk communication isn’t because of bureaucratic timidity. It’s because risk is multidimensional, complicated to quantify, and even more difficult to communicate. This is especially true with infectious diseases, as risk changes with time and varies across different people, and individual-level risk needs to be weighed with population-level risk.

Nonetheless, this post is an attempt to answer this challenge; an attempt to help you think about the quantitative, average risk of COVID-19 from multiple perspectives.

First, we need to recognize that risk calibration is about more than just numbers. Objective numbers cannot be separated from subjective experience when assessing risk. In other words, risk calibration is based on the statistical and physiological chances of disease but also dependent on where you were born, where you live, who you are, how often you do something, the reality you’re forced to navigate, and the complexity of decision-making.

Advertisement
Advertisement

For example, it’s no coincidence that more Black and Hispanic people think schools should continue to require masks compared to whites. Black or Hispanic parents are also more worried about their child getting seriously sick from COVID-19 than white parents. While risk of COVID-19 is biologically the same, what perpetuates that disease is not. Risk calibration is influenced by inequities. For example, Black and Hispanic people were/are more likely to die from COVID-19 due to a myriad of social reasons. The trauma from losing someone close to you or losing millions in a community can impact risk calibration. For parents, dire consequences of missing work because of a school exposure may impact risk calibration.

Advertisement

So, while this post provides many quantitative numbers, please recognize that numbers are only half the story when calibrating or recalibrating individual-risk. Numbers shouldn’t (always) discount subjective experience; it’s a balance.

Risk of dying from COVID-19

The risk of dying from COVID-19 is decreasing over time thanks to vaccines, infection-induced immunity, therapeutics, better understanding of care, and many more factors. In the UK, the risk of mortality from an infection is about 0.1 percent right now.

Advertisement
Advertisement
Advertisement

But, what does 0.1 percent actually mean? For non-epidemiologists, it’s much more helpful to look at “relative risk.” In other words, how does the risk of dying from COVID-19 compare to other things in our world that we are much more familiar with? For example, the chart below compares the infection fatality ratio of COVID-19 to flu.

A chart showing that COVID-19 has gotten less lethal over time.
Advertisement
Advertisement
Advertisement
Advertisement

In their 2014 book the Norm Chronicles—an entertaining, data-driven guide to the statistics of personal risk—authors Blastland and Spiegelhalter use an ingenious measurement: MicroMort (MM), or a one in a million chance of dying. For example, the average person driving 250 miles is one MM—you have a 1 in 1 million chance of dying if you drive 250 miles. They used this standard of measurement to define risk for all types of random activities. I complied some below:

A table showing some common activities and their MicroMorts. 1 flight = 0.02MM, driving 250 miles = 1MM, 1 general anesthesia procedure = 5MM, 1 skydiving trip = 7MM, 1 full year of active service in Afghanistan in 2011 = 5,000MM
MicroMort (1 in 1 million chance of dying) per activity. Data from Norm Chronicles by Blastland & Spiegelhalter (2014). Table developed by Dr. Katelyn Jetelina/YLE
Advertisement
Advertisement

Because MM’s are standardized, we can compare one activity to another. For example, the risk of giving birth to two kids in the US (420 MM) is roughly the same risk as riding 2,800 miles (across the US) on a motorcycle (448 MM).

We can roughly calculate MM after confirmed COVID-19 infections. I pulled CDC data on cases and mortality, by age and vaccination rates, during the first week of January 2022. After many calculations on my whiteboard, this is what I came up with:

Figures in this table are discussed below.
MicroMort (or one in a million chance of dying) from a COVID-19 infection during the Omicron wave, using CDC case and mortality data from January 1, 2022. Calculations made by Katelyn Jetelina/YLE.
Advertisement

Because “dying from COVID-19” is new in our risk repertoire, we can contextualize it by comparing it to other activities, which may help calibrate risk. For example:

• The risk of a zero- to 4-year-old dying from a COVID-19 infection (227 MM) is about the same as the risk of a mom dying from childbirth in the US. (210 MM).
• For a vaccinated 18- to 49-year-old, the risk of dying from an Omicron infection (90 or 48 MM, depending on boosters) is less than the annual risk of dying on the road (100 MM).
• For a boosted 50- to 64-year-old, the risk of dying from an Omicron infection (516 MM) is about the same risk as driving for 5 years in the U.S. (500 MM).
• For an unvaccinated 65+-year-old, the risk of dying from an Omicron infection (28,978 MM) is about the same as 1.5 years of heroin use (29,550 MM).
• For a boosted 65+-year-old, the risk of dying after an infection (6,023 MM) is about the same as the risk of death in a baby’s year of life (6,600 MM). Or, it’s a little more risky than one year of active service in Afghanistan in 2011 (5,000 MM).

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

There is never zero risk of dying from COVID-19. Nothing has zero risk. But the risk is substantially reduced after vaccines. For some, it may be comparable enough to other things in our life for us to take a deep breath.

But, as we all know, mortality isn’t the only possible outcome of COVID-19 infection.

Risk of COVID-19 hospitalization

Unfortunately we can’t use MM with hospitalizations, because I don’t have the MM—or MH—for hospitalizations from car accidents, for example. But the government of British Colombia compiled the nice table below of the risk of COVID-19 hospitalization after infection based on age, gender, vaccination status, and vaccine dosage. Again, these are percentages, and it’s difficult to know what a percentage actually means. But this tool may be more useful for looking at patterns.

Advertisement

The majority of these numbers are very, very small. For example, for a healthy boosted person, the chance of hospitalization is about 1 in 500 breakthrough infections. But there are still groups with meaningful risk, even when vaccinated. For example, the risk of hospitalization is 1 in 10 for a boosted older adult male with multiple at-risk conditions. (This is why it’s still critical to keep transmission as low as possible. Denmark is learning a hard lesson about this right now.)

A chart illustrating the risk of COVID hospitalization, depending on risk conditions, age, sex, and number of doses. Hospitalization risk for younger people with two or more doses approaches zero. People over 80 face substantial risk (around 10%) even with three doses if they have multiple risk conditions.
Health Sector Information, Analysis and Reporting · Government of British Columbia
Advertisement
Advertisement

The chart above isn’t useful for parents, as risk is lumped for age groups less than 20 years old. So I pulled a table I compiled from a previous YLE post that shows the risk of hospitalization by age group assuming no vaccination.

Children 0-4 have a rate of RSV hospitalization per 100,000 of 2381-111 (decreasing with age), of flu hospitalization of 181-41, and of COVID hospitalization of 89. For older children, the risks are lower and remain comparable.
Annual rate of hospitalizations for viral diseases per 100,000 children in the United States. Table created by Katelyn Jetelina/YLE, based on data from two sources: RSV/Flu from Goldstein et al and COVID19 from CDC’s COVIDNet.
Advertisement
Advertisement
Advertisement

Here we can see that risk of hospitalization for children from a COVID-19 infection is variable by age, but largely comparable to RSV and flu.

Risk of long COVID-19

The risk of long COVID-19 from an infection is certainly real. There have been hundreds and hundreds of publications showing a detrimental impact of long-term SARS-CoV-2 on almost every organ in our body system. Among unvaccinated adults, the risk of long COVID-19 after an infection is about 10 to 30 percent. This means a risk of about 1 to 3 in 10 infections. Risk is higher for women and for those initially hospitalized for COVID-19 (hereherehere). But long COVID-19 occurs after asymptomatic infections, too. Some countries, like Finland, estimate long COVID to be higher. In one meta-analysis, 45 studies found 72 percent of people (mostly hospitalized) reported at least one symptom for 12+ weeks after initial COVID-19 infection. Thankfully, the risk of long COVID-19 among kids remains relatively low (around 2-7 percent).

Advertisement
Advertisement

But here as well, vaccines help. A number of articles have shown vaccines reduce the chances of long COVID-19:

• A study in the New England Journal of Medicine found the rate of long COVID-19 among vaccinated hospital workers was 0.5 percent. This equates to about 1 in 200 breakthrough cases.
• Another study in the Lancet found the rate of long COVID-19 among fully vaccinated breakthrough cases was half the rate among unvaccinated (5.2 percent vs. 11.4 percent). Here, the risk of long COVID-19 among vaccinated is 1 in 20 breakthrough cases.
• A more recent preprint study also found vaccination to reduce long COVID-19 by 40 percent (9.5 percent vs. 14.6 percent). This equates to 1 in 10 breakthrough cases.

Advertisement
Advertisement

So vaccines help reduce the chances of long COVID-19, but we don’t know by exactly how much yet, as estimates vary greatly.

Risk of infection

All of these risk estimates are anchored on getting infected in the first place. Unfortunately, risk of infection is one of the most difficult to calibrate because it changes dramatically with the ebb and flow of the virus. In short, the chances of infection are dependent on two things:

1. Coming in contact with an infected person; and,
2. The infected person transmitting the virus to you.

The chances that you show up to an event and someone has COVID-19 (whether they know it or not) are dependent on level of community transmission and number of people at that location. For example, let’s say we have 15 people at my office in Texas. What is the chance that at least one person in the group was COVID-19 positive during the omicron wave? This depends on where we were at during the wave:

Advertisement

• Peak: There was a 99.5 percent chance that at least one person in the group was positive.
• Halfway down the peak: 91.3 percent chance
• Tail end of the peak (where Texas currently is): 54 percent chance
• End of the Omicron wave: 14 percent chance

Advertisement
Advertisement
Advertisement

The more people you have and the more transmission you have, the more likely the virus is there, too.

A line graph illustrating the figures discussed above.
Chance at least one person in a group is COVID19 positive. Graph by Katelyn Jetelina/YLE, modeling from Bob Watcher
Advertisement

Of course, if someone is infected, this doesn’t automatically mean you’ll be infected. The virus still needs to be effectively transmitted. And SARS-CoV-2 is becoming better and better at transmitting because it’s getting better and better at evading our immunity.

But vaccines still help. A recent study found that, on average, a household index case (i.e., someone infected in a household) will transmit the virus to other people in the household 68 percent of the time. If the index case was boosted or previously infected, household transmission only happened about 50 percent of the time. So, if you have the virus and are boosted, transmission is basically the flip of a coin. (It’s reasonable to think that transmission would be less frequent in an office or encountering an infected person at the grocery store, since you’re spending less time with them than if you live in the same household.) But we have other ways to break transmission chains, too. Like ventilation, antigen testing, and masks.

Bottom line

Risk calibration is incredibly complicated and hard to do. I find myself lost in this all the time. But, sticking to two themes helps:

1. When transmission is low, relax. When transmission is high, take precautions. Reasonable measures can prevent infection and, perhaps more importantly, prevent transmission to vulnerable pockets of society. But if you do get infected…
2. Vaccines do a superb job of keeping us out of the hospital.

We’ve done the best we can in an evolving landscape without clear risk communication. But we, public health practitioners, need to do better. Risk communication can and should to be part of our arsenal of preparedness for the next waves and public health threats beyond.

Future Tense is a partnership of Slate, New America, and Arizona State University that examines emerging technologies, public policy, and society.

Advertisement